Director of Strategy & Impact at Nushama.

Julia Mirer M.D. is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging them to help create a new paradigm for integrative health and wellness.

Nationally, Dr. Mirer is an advisor for the Psychedelic Medicine Coalition which is lobbying for psychedelic research funding. In Florida, she works in psychedelic clinical research at Segal Trials as a facilitator, most recently for USONA’s phase 2 trial using Psilocybin for Major Depression.

‍